Our Genetic
Chromosomal Microarray Analysis (CMA)
Chromosomal microarray analysis (CMA) is recommended for analyzing cytogenic variations in patients suffering for unexplained developmental delays, intellectual disabilities, autism spectrum disorders, and/or multiple congenital malformations.
Do you know
Cytogenic variations are known to cause a broad range of developmental disorders, primarily neurodevelopmental and congenital anomalies.
HIGH RESOLUTION AND BROAD COVERAGE
Optimized probe spacing, focusing on exonic regions to provide the best cytogenetic disease variant coverage
DISEASE-FOCUSED CONTENT
Platform designed to represent latest clinical and genetic insights based on ClinGen, DDG2P, ClinVar, PharmGKB, NHGRI-EBI, and GWAS database
QUALITY ANALYSIS
Delivering high-quality analysis via extensive genome-wide cytogenetic analyisis to detect structural aberrations, such as CNVs, chromosomal imbalances, LOH, UPD, and mosaicism
WIDE RANGE OF SAMPLE TYPES
CentoCard®, EDTA blood, ready to use DNA, buccal swab, chronic villi, and amniotic fluid
Testing with CentoArray®
Built on the latest genetic and medical insights. Covering more than 4,800 cytogenetic relevant genes with exon level resolution.
Early and accurate answers
Short turnaround time of 15 business days
what you should know about
Chromosomal microarray analysis (CMA)
- As a first-step analysis for cases of unexplained developmental delays, intellectual disabilities, autism spectrum disorders, and/or multiple congenital malformations
- For deletion/duplication analysis of extremely large genes where gross deletions involving large segments of genes, flanking intergenic regions, or neighboring genes are frequently reported
- To diagnose uniparental disomy (UPD) and regions exhibiting loss/absence of heterozygosity (LOH)
- In conjunction with whole exome sequencing (CentoXome) to complement large CNVs. CentoArray can be ordered either as a step-wise analysis after CentoXome or together as a single-step approach
- For prenatal testing to help determine a cause of ultrasound-detected abnormalities via CentoArray Prenatal
Our CMA Platform designed to represent latest clinical and genetic insights with more than 4,800 cytogenic relevant genes based on ClinGen, DDG2P, ClinVar, PharmGKB, NHGRI-EBI, and GWAS database
Chromosomal microarray analysis (CMA)
is recommended for analyzing cytogenic variations in patients suffering for unexplained developmental delays, intellectual disabilities, autism spectrum disorders, and/or multiple congenital malformations.
We Offer Financial & Superior Services
A small river named Duden flows by their place and supplies it with the necessary
regelialia. It is a paradisematic country, in which
Request a Call Back?
our medical experts are always available for your support before, during and after the analysis.
goanicgeneticlaboratoryservice@gmail.com
+2347068951861